$RMNI
Rimini Street, Inc. Stock $rmni

$rmni Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000163528223000137 Filed on May 03, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$106.4M	$105.5M
YoY Change	5.16%	7.76%
Cost Of Revenue	$39.35M	$39.34M
YoY Change	5.37%	5.74%
Gross Profit	$67.07M	$66.17M
YoY Change	5.04%	9.0%
Gross Profit Margin	63.03%	62.71%
Selling, General & Admin	$56.15M	$52.71M
YoY Change	1.96%	2.04%
% of Gross Profit	83.71%	79.65%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$636.0K	$613.0K
YoY Change	-1.4%	6.24%
% of Gross Profit	0.95%	0.93%
Operating Expenses	$56.15M	$55.48M
YoY Change	-3.47%	1.32%
Operating Profit	$10.92M	$10.69M
YoY Change	92.05%	79.82%
Interest Expense	-$1.687M	-$1.339M
YoY Change	-29.68%	228.09%
% of Operating Profit	-15.44%	-12.53%
Other Income/Expense, Net	$580.0K	$528.0K
YoY Change	-136.78%	152.63%
Pretax Income	$9.188M	$9.874M
YoY Change	195.24%	84.8%
Income Tax	$4.920M	$4.235M
% Of Pretax Income	53.55%	42.89%
Net Earnings	$4.268M	$5.639M
YoY Change	3780.0%	82.67%
Net Earnings / Revenue	4.01%	5.34%
Basic Earnings Per Share	$0.05	$0.06
Diluted Earnings Per Share	$0.05	$0.06
COMMON SHARES
Basic Shares Outstanding	88.91M shares	88.81M shares
Diluted Shares Outstanding	89.27M shares	89.06M shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$140.7M	$135.0M
YoY Change	-12.2%	-14.61%
Cash & Equivalents	$123.5M	$116.2M
Short-Term Investments	$17.13M	$18.79M
Other Short-Term Assets	$39.26M	$37.52M
YoY Change	17.28%	12.94%
Inventory
Prepaid Expenses	$21.24M	$19.91M
Receivables	$85.07M	$89.32M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$265.0M	$261.8M
YoY Change	-5.79%	-7.35%
LONG-TERM ASSETS
Property, Plant & Equipment	$14.27M	$12.88M
YoY Change	-12.93%	-24.32%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$91.59M	$93.43M
YoY Change	3.46%	5.9%
Total Long-Term Assets	$105.9M	$106.3M
YoY Change	0.9%	1.02%
TOTAL ASSETS
Total Short-Term Assets	$265.0M	$261.8M
Total Long-Term Assets	$105.9M	$106.3M
Total Assets	$370.9M	$368.1M
YoY Change	-3.98%	-5.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.632M	$5.956M
YoY Change	-20.26%	64.53%
Accrued Expenses	$58.08M	$58.43M
YoY Change	-8.98%	-6.94%
Deferred Revenue	$259.1M	$257.3M
YoY Change	1.45%	3.54%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$6.258M	$5.349M
YoY Change	70.8%	45.99%
Total Short-Term Liabilities	$329.2M	$329.6M
YoY Change	-0.56%	2.99%
LONG-TERM LIABILITIES
Long-Term Debt	$67.11M	$68.56M
YoY Change	-7.92%	-12.96%
Other Long-Term Liabilities	$36.58M	$1.896M
YoY Change	1180.71%	-33.52%
Total Long-Term Liabilities	$103.7M	$70.45M
YoY Change	36.9%	-13.68%
TOTAL LIABILITIES
Total Short-Term Liabilities	$329.2M	$329.6M
Total Long-Term Liabilities	$103.7M	$70.45M
Total Liabilities	$432.9M	$438.2M
YoY Change	-6.44%	-5.78%
SHAREHOLDERS EQUITY
Retained Earnings	-$218.4M	-$222.6M
YoY Change	-1.9%	-0.03%
Common Stock	$9.000K	$9.000K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$1.116M
YoY Change		0.0%
Treasury Stock Shares
Shareholders Equity	-$62.06M	-$70.12M
YoY Change
Total Liabilities & Shareholders Equity	$370.9M	$368.1M
YoY Change	-3.98%	-5.08%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	$4.268M	$5.639M
YoY Change	3780.0%	82.67%
Depreciation, Depletion And Amortization	$636.0K	$613.0K
YoY Change	-1.4%	6.24%
Cash From Operating Activities	$13.11M	$8.643M
YoY Change	-12.18%	-81.15%
INVESTING ACTIVITIES
Capital Expenditures	$1.066M	$1.029M
YoY Change	-186.18%	-312.16%
Acquisitions
YoY Change
Other Investing Activities	$272.0K	$683.0K
YoY Change
Cash From Investing Activities	-$794.0K	-$346.0K
YoY Change	-35.81%	-28.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-2.247M	-$1.101M
YoY Change	-66.12%	-73.13%
NET CHANGE
Cash From Operating Activities	13.11M	$8.643M
Cash From Investing Activities	-794.0K	-$346.0K
Cash From Financing Activities	-2.247M	-$1.101M
Net Change In Cash	10.06M	$7.161M
YoY Change	42.69%	-81.39%
FREE CASH FLOW
Cash From Operating Activities	$13.11M	$8.643M
Capital Expenditures	$1.066M	$1.029M
Free Cash Flow	$12.04M	$7.614M
YoY Change	-25.5%	-83.57%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q3	us-gaap	Debt Instrument Term DebtInstrumentTerm	P5Y
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001635282
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherAccruedLiabilitiesCurrent
CY2023Q1	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherAccruedLiabilitiesCurrent
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-37397
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	Rimini Street, Inc.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	36-4880301
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	7251 West Lake Mead Blvd.
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 300
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Las Vegas
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NV
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	89128
CY2023Q1	dei	City Area Code CityAreaCode	(702)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	839-9671
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	88914000	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	116169000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	109008000	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	426000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	426000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	745000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	723000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	89317000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	116093000	usd
CY2023Q1	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	17184000	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	17218000	usd
CY2023Q1	us-gaap	Short Term Investments ShortTermInvestments	18785000	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	20115000	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	19910000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	18846000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	261791000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	281706000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	16015000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	15441000	usd
CY2023Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	6554000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	6113000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6325000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7142000	usd
CY2023Q1	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	22115000	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	23508000	usd
CY2023Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	6619000	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	7057000	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	64700000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	65515000	usd
CY2023Q1	us-gaap	Assets Assets	368104000	usd
CY2022Q4	us-gaap	Assets Assets	391041000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	5349000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	4789000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	5956000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	8040000	usd
CY2023Q1	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	31375000	usd
CY2022Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	37459000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	25568000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	32676000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4047000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4223000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	257329000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	265840000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	329624000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	353027000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	68558000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	70003000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	30052000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	34081000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	8093000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	9094000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1896000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2006000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	438223000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	468211000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	99820000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	99820000	shares
CY2023Q1	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	180000	shares
CY2022Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	180000	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	88883000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	88883000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	88517000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	88517000	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	9000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	9000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	158449000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	156401000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4831000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4195000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-222630000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-228269000	usd
CY2023Q1	us-gaap	Treasury Stock Value TreasuryStockValue	1116000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1116000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-70119000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-77170000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	368104000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	391041000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	105512000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	97910000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	39343000	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	37207000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	66169000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	60703000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	34479000	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	31700000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	18227000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	19951000	usd
CY2023Q1	us-gaap	Restructuring Costs RestructuringCosts	59000	usd
CY2022Q1	us-gaap	Restructuring Costs RestructuringCosts	0	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	2719000	usd
CY2022Q1	us-gaap	Professional Fees ProfessionalFees	3499000	usd
CY2023Q1	rmni	Insurance Costs And Recoveries Net InsuranceCostsAndRecoveriesNet	0	usd
CY2022Q1	rmni	Insurance Costs And Recoveries Net InsuranceCostsAndRecoveriesNet	-389000	usd
CY2023Q1	rmni	Litigation Costs Net Of Refunds And Recoveries LitigationCostsNetOfRefundsAndRecoveries	-2719000	usd
CY2022Q1	rmni	Litigation Costs Net Of Refunds And Recoveries LitigationCostsNetOfRefundsAndRecoveries	-3110000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	55484000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	54761000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	10685000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	5942000	usd
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	1339000	usd
CY2022Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	808000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	528000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	209000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	9874000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5343000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4235000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2256000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	5639000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	3087000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	139000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-186000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-775000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	0	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	5003000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2901000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	5639000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3087000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	88690000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	87124000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	89061000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	88485000	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-77170000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-80386000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-70119000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-77299000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	5639000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	3087000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1976000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3051000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	613000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	577000	usd
CY2023Q1	rmni	Accretion And Amortization Of Debt Discount And Issuance Costs AccretionAndAmortizationOfDebtDiscountAndIssuanceCosts	240000	usd
CY2022Q1	rmni	Accretion And Amortization Of Debt Discount And Issuance Costs AccretionAndAmortizationOfDebtDiscountAndIssuanceCosts	240000	usd
CY2023Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	496000	usd
CY2022Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	671000	usd
CY2023Q1	rmni	Increase Decrease In Operating Lease Right Of Use Assets And Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndOperatingLeaseLiabilities	-1147000	usd
CY2022Q1	rmni	Increase Decrease In Operating Lease Right Of Use Assets And Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndOperatingLeaseLiabilities	-1403000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-26945000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-44980000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	425000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	490000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-1427000	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	2312000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2087000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2277000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-14844000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2815000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-12484000	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-266000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	8643000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	45849000	usd
CY2023Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	1029000	usd
CY2022Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	485000	usd
CY2023Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	7713000	usd
CY2022Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	usd
CY2023Q1	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	8396000	usd
CY2022Q1	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-346000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-485000	usd
CY2023Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2022Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	27000	usd
CY2023Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	1125000	usd
CY2022Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	1125000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3240000	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	47000	usd
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	81000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	71000	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	375000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1101000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4098000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-35000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-2791000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	7161000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	38475000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	109434000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	119990000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	116595000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	158465000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	1112000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	568000	usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	2794000	usd
CY2022Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	544000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	usd
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	168000	usd
CY2023Q1	rmni	Working Capital Surplus Deficit WorkingCapitalSurplusDeficit	67800000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	5600000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	116600000	usd
CY2023Q1	us-gaap	Short Term Investments ShortTermInvestments	18800000	usd
CY2023Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	257300000	usd
CY2023Q1	rmni	Cost Of Goods And Services Sold As Percentage Of Revenue CostOfGoodsAndServicesSoldAsPercentageOfRevenue	0.37
CY2021Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	90000000	usd
CY2021Q3	us-gaap	Debt Instrument Term DebtInstrumentTerm	P5Y
CY2021Q3	rmni	Long Term Debt Maturities Repayments Of Principal Percentage In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalPercentageInNextTwelveMonths	0.05
CY2021Q3	rmni	Long Term Debt Maturities Repayments Of Principal Percentage In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalPercentageInYearTwo	0.05
CY2021Q3	rmni	Long Term Debt Maturities Repayments Of Principal Percentage In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalPercentageInYearThree	0.075
CY2021Q3	rmni	Long Term Debt Maturities Repayments Of Principal Percentage In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalPercentageInYearFour	0.075
CY2021Q3	rmni	Long Term Debt Maturities Repayments Of Principal Percentage In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalPercentageInYearFive	0.10
CY2023Q1	rmni	Lessee Lease Liability Payments Due Next Rolling Twelve Months LesseeLeaseLiabilityPaymentsDueNextRollingTwelveMonths	4400000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements and related disclosures in conformity with U.S. GAAP requires the Company to make judgments, assumptions, and estimates that affect the amounts reported in its consolidated financial statements and </span></div>accompanying notes. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes are reasonable under the circumstances to determine the carrying values of assets and liabilities that are not readily apparent from other sources. The Company’s accounting estimates include, but are not necessarily limited to, valuation of accounts receivable, valuation assumptions for stock options and leases, deferred income taxes and the related valuation allowances, and the evaluation and measurement of contingencies. To the extent there are material differences between the Company’s estimates and actual results, the Company’s future consolidated results of operations may be affected.
CY2023Q1	rmni	Contract With Customer Liability Revenue Recognized Including Current Billings ContractWithCustomerLiabilityRevenueRecognizedIncludingCurrentBillings	105512000	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	40726000	usd
CY2021Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	36509000	usd
CY2023Q1	rmni	Capitalized Commissions CapitalizedCommissions	3162000	usd
CY2022Q1	rmni	Capitalized Commissions CapitalizedCommissions	6525000	usd
CY2023Q1	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	4589000	usd
CY2022Q1	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	4213000	usd
CY2023Q1	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	39299000	usd
CY2022Q1	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	38821000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	299921000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	300268000	usd
CY2023Q1	us-gaap	Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress	92972000	usd
CY2022Q1	us-gaap	Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress	97671000	usd
CY2022Q1	rmni	Contract With Customer Liability Revenue Recognized Including Current Billings ContractWithCustomerLiabilityRevenueRecognizedIncludingCurrentBillings	97910000	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	287381000	usd
CY2022Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	300029000	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	556100000	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	287400000	usd
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	556900000	usd
CY2022Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	300000000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	257300000	usd
CY2023Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	6481000	usd
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	6878000	usd
CY2023Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	4783000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	9184000	usd
CY2023Q1	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	20000	usd
CY2022Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	2526000	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	372000	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	333000	usd
CY2023Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	2185000	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	2229000	usd
CY2023Q1	us-gaap	Accrued Insurance Current And Noncurrent AccruedInsuranceCurrentAndNoncurrent	6982000	usd
CY2022Q4	us-gaap	Accrued Insurance Current And Noncurrent AccruedInsuranceCurrentAndNoncurrent	6979000	usd
CY2023Q1	rmni	Other Accrued Expenses Current OtherAccruedExpensesCurrent	4745000	usd
CY2022Q4	rmni	Other Accrued Expenses Current OtherAccruedExpensesCurrent	4547000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	25568000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	32676000	usd
CY2022Q2	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	50000000	usd
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	1339000	usd
CY2022Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	808000	usd
CY2022Q2	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	15000000	usd
CY2022Q2	us-gaap	Stock Repurchase Program Period In Force1 StockRepurchaseProgramPeriodInForce1	P2Y
CY2022Q2	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	50000000	usd
CY2022Q2	us-gaap	Stock Repurchase Program Period In Force1 StockRepurchaseProgramPeriodInForce1	P4Y
CY2022Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	15000000	usd
CY2022Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	15000000	usd
CY2022Q1	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	600000	shares
CY2022Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	3200000	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	3500000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	400000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	7543000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	3541000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	695000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	482000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	82000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	175000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	129000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	10293000	shares
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.55
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0405
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	4.78
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1976000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3051000	usd
CY2023Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	3400000	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	5.64
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.429
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.422
CY2023Q1	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	800000	usd
CY2022Q1	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	800000	usd
CY2023Q1	us-gaap	Guarantee Obligations Current Carrying Value GuaranteeObligationsCurrentCarryingValue	11700000	usd
CY2022Q4	us-gaap	Guarantee Obligations Current Carrying Value GuaranteeObligationsCurrentCarryingValue	8100000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	5639000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	3087000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	88690000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	87124000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	89061000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	88485000	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11208000	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	23654000	shares
CY2023Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	20000000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	1147000	usd
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	1403000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	20209000	usd
CY2023Q1	us-gaap	Aoci Debt Securities Available For Sale Without Allowance For Credit Loss Cumulative Gain Loss After Tax AociDebtSecuritiesAvailableForSaleWithoutAllowanceForCreditLossCumulativeGainLossAfterTax	175000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	20384000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	105512000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	97910000	usd
CY2023Q1	rmni	Lessee Operating Lease Terms Days Notice Required To Terminate LesseeOperatingLeaseTermsDaysNoticeRequiredToTerminate	30	day
CY2023Q1	rmni	Other Lease Cost OtherLeaseCost	48000	usd
CY2022Q1	rmni	Other Lease Cost OtherLeaseCost	193000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	1195000	usd
CY2022Q1	us-gaap	Lease Cost LeaseCost	1596000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6325000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7142000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4047000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4223000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	8093000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	9094000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	12140000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	13317000	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y29D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.103
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths	3831000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Two LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo	4647000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Three LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree	3055000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Four LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour	2445000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Five LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive	208000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Rolling Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive	0	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	14186000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	2046000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	12140000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	1100000	usd
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	1400000	usd

Files In Submission

Name	View Source	Status
rmni-20230331_def.xml	Edgar Link	unprocessable
0001635282-23-000137-index-headers.html	Edgar Link	pending
0001635282-23-000137-index.html	Edgar Link	pending
0001635282-23-000137.txt	Edgar Link	pending
0001635282-23-000137-xbrl.zip	Edgar Link	pending
exhibit311q12023.htm	Edgar Link	pending
exhibit312q12023.htm	Edgar Link	pending
exhibit321q12023.htm	Edgar Link	pending
exhibit322q12023.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
rmni-20230331.htm	Edgar Link	pending
rmni-20230331.xsd	Edgar Link	pending
Show.js	Edgar Link	pending
rmni-20230331_cal.xml	Edgar Link	unprocessable
rmni-20230331_lab.xml	Edgar Link	unprocessable
rmni-20230331_pre.xml	Edgar Link	unprocessable
rmni-20230331_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RMNI
Rimini Street, Inc. Stock $rmni

2023 Q2 Form 10-Q Financial Statement

#000163528223000137 Filed on May 03, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RMNI Rimini Street, Inc. Stock $rmni

2023 Q2 Form 10-Q Financial Statement

#000163528223000137 Filed on May 03, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RMNI
Rimini Street, Inc. Stock $rmni